Fusion Antibodies plc

LSE (GBp): Fusion Antibodies plc (FAB)

Last Price

6.71

Today's Change

+0.262 (4.059%)

Day's Change

6.61 - 7.09

Trading Volume

1,439,949

Overview

Market Cap

7 Million

Shares Outstanding

113 Million

Avg Volume

792,662

Avg Price (50 Days)

6.51

Avg Price (200 Days)

5.88

PE Ratio

-3.36

EPS

-0.02

Earnings Announcement

28-May-2025

Previous Close

6.45

Open

6.74

Day's Range

6.61 - 7.0964

Year Range

2.8 - 12.0

Trading Volume

1,439,949

Price Change Highlight

1 Day Change

4.06%

5 Day Change

3.26%

1 Month Change

-0.56%

3 Month Change

-16.62%

6 Month Change

57.93%

Ytd Change

-17.64%

1 Year Change

81.90%

3 Year Change

-88.12%

5 Year Change

-93.61%

10 Year Change

-94.57%

Max Change

-94.57%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Fusion Antibodies plc, a contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies primarily for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally. It offers monoclonal antibody discovery and development, antibody sequencing, antibody engineering, antibody humanization and rational affinity maturation platform, recombinant protein expression, and stable cell line development and cGMP scale up services. The company serves pharmaceutical, biotech, and diagnostic companies. It has a collaboration partnership with Celonic AG. Fusion Antibodies plc was incorporated in 2000 and is headquartered in Belfast, the United Kingdom.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment